We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

9 hedge funds and large institutions have $17.3M invested in TriSalus Life Sciences in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

86.76% less ownership

Funds ownership: 93.64% → 6.88% (-87%)

88% less funds holding

Funds holding: 72 → 9 (-63)

92% less capital invested

Capital invested by funds: $225M → $17.3M (-$207M)

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 64

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
9
Holders Change
-63
Holders Change %
-87.5%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
64
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$124K
2
UBS Group
UBS Group
Switzerland
+$20.4K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$27.1M
2
DM
Deerfield Management
New York
-$9.93M
3
GCL
Glazer Capital LLC
New York
-$9.56M
4
Marshall Wace
Marshall Wace
United Kingdom
-$7.9M
5
HSBC Holdings
HSBC Holdings
United Kingdom
-$7.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
– -$4.55M -457,874 Closed
MSU
27
Mizuho Securities USA
New York
– -$4.51M -457,429 Closed
WCMNY
28
Westchester Capital Management (New York)
New York
– -$4.11M -414,265 Closed
Nomura Holdings
29
Nomura Holdings
Japan
– -$3.99M -401,757 Closed
Tudor Investment Corp
30
Tudor Investment Corp
Connecticut
– -$3.99M -401,403 Closed
AA
31
AQR Arbitrage
Connecticut
– -$3.98M -400,717 Closed
MP
32
MSD Partners
New York
– -$3.97M -400,000 Closed
WAM
33
Weiss Asset Management
Massachusetts
– -$3.3M -332,175 Closed
Hudson Bay Capital Management
34
Hudson Bay Capital Management
Connecticut
– -$3.3M -331,945 Closed
CH
35
CVI Holdings
Delaware
– -$2.98M -299,993 Closed
SV
36
Starboard Value
New York
– -$2.96M -298,368 Closed
BCL
37
Bracebridge Capital LLC
Massachusetts
– -$2.94M -296,572 Closed
Barclays
38
Barclays
United Kingdom
– -$2.94M -296,422 Closed
Balyasny Asset Management
39
Balyasny Asset Management
Illinois
– -$2.85M -286,532 Closed
VI
40
Vestcor Inc
New Brunswick, Canada
– -$2.74M -276,074 Closed
MA
41
MYDA Advisors
New York
– -$2.68M -270,000 Closed
BCM
42
Basso Capital Management
Connecticut
– -$2.48M -249,569 Closed
PC
43
Periscope Capital
Ontario, Canada
– -$2.22M -223,656 Closed
Point72 Asset Management
44
Point72 Asset Management
Connecticut
– -$1.99M -200,000 Closed
ZCA
45
Zeke Capital Advisors
Pennsylvania
– -$1.99M -200,000 Closed
FTCM
46
Fir Tree Capital Management
New York
– -$1.66M -167,450 Closed
Millennium Management
47
Millennium Management
New York
– -$1.66M -166,908 Closed
ECU
48
Eisler Capital (UK)
United Kingdom
– -$1.63M -164,122 Closed
Goldman Sachs
49
Goldman Sachs
New York
– -$1.35M -135,789 Closed
KIM
50
Karpus Investment Management
New York
– -$1.3M -131,000 Closed
1
2
3

TLSI Hedge Fund Activity: Q4 2022 in Review

9 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q4 2022, worth a combined $17.3M — down 92% from $225M a quarter earlier.

Sellers outnumbered buyers: 64 funds closed out of TLSI and 1 opened new positions — a net loss of 63 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $124K. The largest seller was BlackRock, exiting entirely with an estimated $27.1M sold.

  • 9 institutional investors held TriSalus Life Sciences (TLSI) as of Q4 2022, down from 72 in Q3 2022.
  • Funds reported $17.3M of TriSalus Life Sciences stock for Q4 2022, down 92% quarter-over-quarter.
  • 1 fund opened new TriSalus Life Sciences positions in Q4 2022 and 64 closed out, a net change of -63 holders.
  • The largest TriSalus Life Sciences buyer in Q4 2022 was Virtu Financial, an estimated $124K added.
  • The largest TriSalus Life Sciences seller in Q4 2022 was BlackRock, an estimated $27.1M sold.

Based on aggregated 13F filings for Q4 2022.